Organovo Holdings Inc. Stock
Price
Target price
-
-
-
-
-
-
WKN: A2QA6Q / Symbol: ONVO / Name: Organovo / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Organovo Holdings Inc. Stock
Our community identified positive and negative aspects for Organovo Holdings Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Organovo Holdings Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Organovo Holdings Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Organovo Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Organovo Holdings Inc. | - | - | - | - | - | - | - |
| Chromadex Corp | -0.840% | -2.459% | 22.680% | 337.500% | 131.068% | 674.740% | 216.489% |
| Intellia Therapeutics Inc | -2.650% | 14.768% | 9.622% | -63.801% | -26.423% | -79.575% | -54.849% |
| Polynovo Ltd | 2.330% | -8.511% | -20.859% | -57.843% | -46.694% | -25.862% | -57.285% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-11-25
At first glance, Organovo's financials present a company deep in the investment phase, as indicated by their consistent negative net income and heavy reliance on research and development. Biotechnology is an industry known for its lengthy and capital-intensive path to commercial viability, and Organovo's financials are reflective of these sector-specific challenges.
*Pros: *
*Cons: *
Comments
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat
Organovo Holdings, Inc. (NASDAQ: ONVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ONVO provided by MarketBeat
News
Why Eli Lilly Stock Popped Today
Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases.
In one, Lilly announced plans to acquire the farnesoid X
